In addition, peripheral cytokines levels such as IL-1β, IL-2, IL-6, IL-12, IL-18, IL-23, and TGF-β were seen to be altered in AD patients and could be used as candidate biomarkers [281,282,283,284]. Here, IL1B is linked to Alzheimer disease.